Page last updated: 2024-10-29

iohexol and Maxillary Neoplasms

iohexol has been researched along with Maxillary Neoplasms in 2 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Maxillary Neoplasms: Cancer or tumors of the MAXILLA or upper jaw.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rødal, J1
Søvik, S1
Skogmo, HK1
Knudtsen, IS1
Malinen, E1
Apajalahti, S1
Hagström, J1
Lindqvist, C1
Suomalainen, A1

Other Studies

2 other studies available for iohexol and Maxillary Neoplasms

ArticleYear
Feasibility of contrast-enhanced cone-beam CT for target localization and treatment monitoring.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2010, Volume: 97, Issue:3

    Topics: Animals; Cone-Beam Computed Tomography; Contrast Media; Dog Diseases; Dogs; Dose Fractionation, Radi

2010
Computerized tomography findings and recurrence of keratocystic odontogenic tumor of the mandible and maxillofacial region in a series of 46 patients.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2011, Volume: 111, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Contrast Media; Female; Follow-Up Studies; Humans

2011